HighMark Wealth Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-438
Closed -$60K 497
2020
Q3
$60K Buy
438
+392
+852% +$41.7K 0.05% 94
2020
Q2
$53K Buy
+46
New +$3.84K 0.06% 78

HighMark Wealth Management's MYOK Position: Q4 2020 in Review

HighMark Wealth Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 438 shares — an estimated $60K sold.

HighMark Wealth Management first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $60K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • HighMark Wealth Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • HighMark Wealth Management sold 438 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $60K.
  • HighMark Wealth Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • HighMark Wealth Management's MyoKardia, Inc. Common Stock position peaked at $60K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on HighMark Wealth Management's 13F filing for Q4 2020, filed 27 Jan 2021.